Agilent Technologies, Inc. $A Holdings Increased by Cardinal Capital Management

Cardinal Capital Management lifted its position in shares of Agilent Technologies, Inc. (NYSE:A) by 3.8% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 78,054 shares of the medical research company’s stock after buying an additional 2,854 shares during the quarter. Agilent Technologies accounts for about 1.6% of Cardinal Capital Management’s holdings, making the stock its 15th biggest position. Cardinal Capital Management’s holdings in Agilent Technologies were worth $13,449,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in A. State Street Corp raised its holdings in Agilent Technologies by 0.7% in the 2nd quarter. State Street Corp now owns 12,854,230 shares of the medical research company’s stock valued at $1,710,658,000 after buying an additional 89,598 shares during the last quarter. Wellington Management Group LLP boosted its position in Agilent Technologies by 2.7% during the 2nd quarter. Wellington Management Group LLP now owns 7,454,686 shares of the medical research company’s stock worth $990,206,000 after buying an additional 198,253 shares during the period. Deutsche Bank AG grew its holdings in Agilent Technologies by 17.1% during the 2nd quarter. Deutsche Bank AG now owns 7,008,634 shares of the medical research company’s stock worth $930,957,000 after acquiring an additional 1,024,516 shares during the last quarter. Bank of New York Mellon Corp grew its holdings in Agilent Technologies by 87.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 5,233,964 shares of the medical research company’s stock worth $695,227,000 after acquiring an additional 2,440,360 shares during the last quarter. Finally, Legal & General Group Plc bought a new stake in Agilent Technologies during the 2nd quarter worth approximately $260,101,000.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, Director Mikael Dolsten sold 634 shares of the company’s stock in a transaction on Friday, September 4th. The shares were sold at an average price of $151.38, for a total transaction of $95,974.92. Following the sale, the director owned 4,924 shares of the company’s stock, valued at approximately $745,395.12. This represents a 11.41% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Agilent Technologies Stock Up 2.8%

Agilent Technologies stock opened at $177.93 on Thursday. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.56 and a current ratio of 2.05. Agilent Technologies, Inc. has a 52-week low of $108.35 and a 52-week high of $178.21. The firm has a 50 day moving average price of $160.50 and a two-hundred day moving average price of $138.97. The firm has a market cap of $50.16 billion, a price-to-earnings ratio of 35.03, a PEG ratio of 2.63 and a beta of 1.21.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 EPS for the quarter, beating analysts’ consensus estimates of $1.49 by $0.13. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. The company had revenue of $1.88 billion for the quarter, compared to analyst estimates of $1.84 billion. During the same period in the prior year, the firm posted $1.37 EPS. The company’s quarterly revenue was up 8.1% on a year-over-year basis. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Equities analysts predict that Agilent Technologies, Inc. will post 6.20 EPS for the current year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 28th. Investors of record on Tuesday, October 6th will be issued a $0.2550 dividend. The ex-dividend date is Tuesday, October 6th. This represents a $1.02 annualized dividend and a yield of 0.6%. Agilent Technologies’s payout ratio is presently 20.08%.

Wall Street Analyst Weigh In

Several brokerages have issued reports on A. Barclays upped their price target on shares of Agilent Technologies from $175.00 to $195.00 and gave the company an “overweight” rating in a research report on Wednesday, October 7th. The Goldman Sachs Group lifted their price target on shares of Agilent Technologies from $155.00 to $175.00 and gave the stock a “buy” rating in a report on Thursday, August 27th. Stifel Nicolaus boosted their price objective on shares of Agilent Technologies from $170.00 to $180.00 and gave the stock a “buy” rating in a research note on Thursday, August 27th. Royal Bank Of Canada increased their price objective on Agilent Technologies from $155.00 to $185.00 and gave the company an “outperform” rating in a report on Thursday, August 27th. Finally, TD Cowen increased their price objective on Agilent Technologies from $180.00 to $196.00 and gave the company a “buy” rating in a report on Tuesday, October 13th. Fifteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat.com, Agilent Technologies has a consensus rating of “Moderate Buy” and an average price target of $173.65.

About Agilent Technologies

Agilent Technologies, Inc is a global provider of analytical laboratory instruments, software, services and consumables. The company serves customers in the pharmaceutical, biotechnology, chemical, food, environmental, energy and academic research sectors, as well as diagnostic and clinical laboratories.

Agilent’s offerings include liquid and gas chromatography systems, mass spectrometry instruments, spectroscopy and atomic instruments, laboratory automation products, genomic and cell analysis solutions, and related software.